Hospital Biz To Benefit From Remote Monitors, Genetic Tests – Health Affairs
This article was originally published in The Gray Sheet
Executive Summary
Remote monitoring devices that demonstrate reduced hospital admissions and emergency room visits present a valid case for reimbursement, according to a Health Affairs article
You may also be interested in...
Healthcare IT Gets Presidential Treatment; Will Device Firms Benefit?
Innovative reimbursement options for healthcare information technology are necessary to advance the market, according to Daniel Mendelson, managing director of The Health Strategies Consultancy
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.